Baillie Gifford & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-54
Closed -$44.4K 411
2023
Q1
$44.4K Buy
54
+7
+15% +$5.75K ﹤0.01% 292
2022
Q4
$33.9K Hold
47
﹤0.01% 310
2022
Q3
$32K Sell
47
-3
-6% -$2.04K ﹤0.01% 304
2022
Q2
$30K Buy
50
+4
+9% +$2.4K ﹤0.01% 310
2022
Q1
$32K Hold
46
﹤0.01% 313
2021
Q4
$29K Sell
46
-9
-16% -$5.67K ﹤0.01% 334
2021
Q3
$33K Sell
55
-8
-13% -$4.8K ﹤0.01% 311
2021
Q2
$35K Hold
63
﹤0.01% 307
2021
Q1
$30K Buy
63
+3
+5% +$1.43K ﹤0.01% 301
2020
Q4
$29K Buy
+60
New +$29K ﹤0.01% 296
2018
Q2
Sell
-5,500
Closed -$1.89M 209
2018
Q1
$1.89M Hold
5,500
﹤0.01% 198
2017
Q4
$2.07M Hold
5,500
﹤0.01% 192
2017
Q3
$2.46M Hold
5,500
﹤0.01% 190
2017
Q2
$2.7M Hold
5,500
﹤0.01% 190
2017
Q1
$2.13M Hold
5,500
﹤0.01% 187
2016
Q4
$2.02M Sell
5,500
-4,600
-46% -$1.69M ﹤0.01% 194
2016
Q3
$4.06M Hold
10,100
0.01% 182
2016
Q2
$3.53M Hold
10,100
0.01% 179
2016
Q1
$3.64M Sell
10,100
-2,600
-20% -$937K 0.01% 180
2015
Q4
$6.89M Sell
12,700
-7,900
-38% -$4.29M 0.01% 154
2015
Q3
$9.58M Hold
20,600
0.02% 150
2015
Q2
$10.5M Hold
20,600
0.02% 144
2015
Q1
$9.3M Hold
20,600
0.02% 153
2014
Q4
$8.45M Hold
20,600
0.02% 156
2014
Q3
$7.43M Sell
20,600
-16,180
-44% -$5.83M 0.02% 160
2014
Q2
$10.4M Hold
36,780
0.02% 152
2014
Q1
$11M Hold
36,780
0.03% 143
2013
Q4
$10.1M Sell
36,780
-2,672
-7% -$735K 0.02% 141
2013
Q3
$12.3M Buy
39,452
+37,780
+2,260% +$11.8M 0.03% 130
2013
Q2
$376K Buy
+1,672
New +$376K ﹤0.01% 152